Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Engineered enzymes turn industrial pollutant Into pharmaceutical building block

By Brian Buntz | December 19, 2025

Structure-guided mutagenesis of fructose-6-phosphate aldolase enabled researchers to achieve 94% conversion of formaldehyde to L-glyceraldehyde in a one-pot aqueous process

Structure-guided mutagenesis of fructose-6-phosphate aldolase enabled researchers to achieve 94% conversion of formaldehyde to L-glyceraldehyde in a one-pot aqueous process

Researchers at Chonnam National University in South Korea have engineered an enzyme cascade that converts formaldehyde into L-glyceraldehyde, a chiral compound used as a building block in pharmaceutical synthesis and in routes to specialty sugars. The one-pot process runs in water under mild conditions and reached roughly 94% conversion efficiency, pointing to a potential approach for detoxifying formaldehyde-containing waste streams while producing a higher-value chemical feedstock.

The study, published in the International Journal of Biological Macromolecules, lands amid growing interest in “C1 biocatalysis,” efforts to use enzymes and microbes to upgrade one-carbon molecules such as formaldehyde, methanol, formate, and CO₂ into multi-carbon products.

Why formaldehyde matters

Formaldehyde is widely used in manufacturing, including as a disinfectant and as a precursor for resins and other intermediates. It is also highly reactive and toxic. Exposure risks have made it a long-running occupational and environmental concern, and health agencies classify it as carcinogenic to humans.

Beyond direct industrial handling, formaldehyde can be generated in the atmosphere through chemical reactions and can off-gas indoors from building materials, furnishings, and consumer products made with formaldehyde-based resins, contributing to higher indoor concentrations in some settings.

Engineering the enzyme for selectivity

The Chonnam team used a structurally engineered fructose-6-phosphate aldolase (GaFSA) from Gilliamella apicola. The enzyme catalyzes carbon-carbon bond formation through an aldol reaction between glycolaldehyde and formaldehyde, yielding L-glyceraldehyde.

Early versions of the system produced substantial amounts of D-threose as a byproduct, cutting into selectivity for the target product. Using structure-guided mutagenesis, the researchers changed two residues (Ser166 and Val203) to suppress D-threose formation and improve selectivity to above 93% under aqueous, mild conditions.

To streamline the workflow, the team coupled the engineered aldolase with an optimized E. coli glyoxylate carboligase (EcGCL) to generate glycolaldehyde in situ from formaldehyde. That removed the need to add glycolaldehyde externally and enabled a single-vessel cascade.

The reaction operates at pH 7.5 and 40°C, proceeds entirely in water, and avoids organic solvents.

Part of a broader C1 biomanufacturing push

Formaldehyde sits in a precarious position for biomanufacturing. It is a useful intermediate for building carbon chains, but its toxicity can damage cells and deactivate biocatalysts. Reviews of C1 biomanufacturing have emphasized both the promise of turning low-value C1 streams into chemicals and the practical challenges in scaling these conversions.

Related research has shown that engineered whole-cell systems can convert formaldehyde into C2 products such as glycolic acid, a reminder that C1 upgrading is not limited to cell-free enzyme cascades.

What comes next

The results are an encouraging proof of concept, but several hurdles remain before any industrial rollout. Formaldehyde’s reactivity can shorten catalyst lifetimes, and long-run stability, regeneration strategies, and continuous-processing designs would all need development. Commercial viability would also depend on the cost and purity of available formaldehyde streams, the value of L-glyceraldehyde in downstream markets, and competition with established synthetic routes.

Still, the work adds to a growing toolkit for converting one-carbon feedstocks into more complex chemicals and suggests a future where at least some hazardous streams can be upgraded rather than simply neutralized.

Related Articles Read More >

R&D 100 Winner Spotlight: A closer look at Thermo Fisher Scientific’s trio of R&D 100 wins in 2025
MIT team uses mysterious cell structure to record genetic activity
This pocket-sized “laboratory” can detect food allergens in minutes
Los Alamos’ R&D 100-winning EpiEarth platform helps predict the global outbreaks early
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2025 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

R&D 100 Awards
Research & Development World
  • Subscribe to R&D World Magazine
  • Sign up for R&D World’s newsletter
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE